Project description DEENESFRITPL Innovative technology for molecular optical imaging in deep tissue Multispectral optoacoustic tomography (MSOT) is an innovative technology that enables molecular optical imaging in deep tissue. The technology is non-invasive and allows assessment of the concentration and distribution of molecules in the body, providing clinically important information on oxygenation, inflammation and tissue fibrosis. Despite its demonstrated scientific and clinical value, MSOT is not commercially available for the clinical market and is currently limited to research environments. The EU-funded FRONTIER project is supporting iThera Medical from Germany in optimising and translating the MSOT system from a research environment to a routine clinical imaging application. Show the project objective Hide the project objective Objective Multispectral optoacoustic tomography (MSOT) is an innovative biomedical imaging technology that allows for molecular imaging in deep tissue. This noninvasive technology enables assessment of the concentration and distribution of a variety of clinically important molecules in the body and uniquely delivers information of e.g. oxygenation, inflammation, and fibrotic changes. MSOT has already demonstrated significant scientific and clinical value across a range of diseases and applications, making it a promising tool to diagnose diseases and monitor treatment response. Despite these early successes, the technology is not yet commercially viable on the broad clinical market and currently remains effectively confined to a research environment. FRONTIER will provide iThera Medical the means to translate an optimized MSOT system (MSOT Frontier) from a research environment to application in routine clinical imaging, thereby providing clinicians worldwide a powerful new diagnostic tool. Programme(s) HORIZON.3.1 - The European Innovation Council (EIC) Main Programme HORIZON.3.1.2 - The Accelerator Topic(s) HORIZON-EIC-2021-ACCELERATORCHALLENGES-01-01 - Strategic Digital and Health Technologies Call for proposal HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 See other projects for this call Funding Scheme HORIZON-AG - HORIZON Action Grant Budget-Based Coordinator ITHERA MEDICAL GMBH Net EU contribution € 2 451 121,00 Address Zielstattstrasse 13 81379 Munchen Germany See on map Region Bayern Oberbayern München, Kreisfreie Stadt Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 1 130 480,23
